Company Overview

Celera Corporation develops, manufactures, and commercializes molecular diagnostic products for personalized disease management. It offers ViroSeq HIV-1, a genotyping system for use in detecting HIV genomic mutations that confer resistance to specific types of antiretroviral drugs as an aid in monitoring and treating HIV infection; Cystic Fibrosis Genotyping Assay, a qualitative in vitro diagnostic device to genotype a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator gene in genomic DNA isolated from human whole blood specimens; m2000, a realtime polymerase chain reaction system for laboratory automation worldwide; reagents for laboratory developed t...

Celera Corporation develops, manufactures, and commercializes molecular diagnostic products for personalized disease management. It offers ViroSeq HIV-1, a genotyping system for use in detecting HIV genomic mutations that confer resistance to specific types of antiretroviral drugs as an aid in monitoring and treating HIV infection; Cystic Fibrosis Genotyping Assay, a qualitative in vitro diagnostic device to genotype a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator gene in genomic DNA isolated from human whole blood specimens; m2000, a realtime polymerase chain reaction system for laboratory automation worldwide; reagents for laboratory developed tests; and transplantation solutions. The company also provides clinical diagnostic tests to identify and characterize risk for cardiovascular (CVD) disease, as well as helps physicians to recommend treatment; and personalized CVD management service, including a Web-based treatment plan and patient compliance system for physicians and patients, as well as develops customized regimens for exercise, nutrition, stress management, and therapy compliance. In addition, it offers CVD management tools and services with a focus on the secondary prevention market; a technology and suite of tests to assist a physician in developing a patient baseline for ongoing patient monitoring; and diagnostic services paired with patient education services, including personalized treatment, CVD patient monitoring over time, and disease management. The company’s products are used to detect, characterize, monitor, and select treatment for diseases. It serves hospitals and other clinical laboratories through a distribution partner. Celera Corporation has strategic alliances with Abbott Laboratories, Seattle Genetics, and Medarex. The company was founded in 1998 and is headquartered in Alameda, California. As of May 10, 2011, Celera Corporation operates as a subsidiary of Quest Diagnostics Inc.

Key Executives for Celera Corporation

Similar Private Companies By Industry

Recent Private Companies Transactions